• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过对慢性阻塞性肺疾病患者进行分组来研究一种复杂干预措施的异质性和成本效益。

Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease.

作者信息

Sørensen Sabrina Storgaard, Jensen Morten Berg, Pedersen Kjeld Møller, Ehlers Lars

机构信息

Department of Business and Management, Danish Center for Healthcare Improvements, Aalborg University, Aalborg, Denmark.

Department of Business and Management, Danish Center for Healthcare Improvements, Aalborg University, Aalborg, Denmark; Department of Economics and Business Economics, Aarhus University, Aarhus V, Denmark.

出版信息

Value Health. 2018 Feb;21(2):239-247. doi: 10.1016/j.jval.2017.08.001. Epub 2017 Sep 12.

DOI:10.1016/j.jval.2017.08.001
PMID:29477406
Abstract

OBJECTIVES

To examine the heterogeneity in cost-effectiveness analyses of patient-tailored complex interventions.

METHODS

Latent class analysis (LCA) was performed on data from a randomized controlled trial evaluating a patient-tailored case management strategy for patients suffering from chronic obstructive pulmonary disease (COPD). LCA was conducted on detailed process variables representing service variation in the intervention group. Features of the identified latent classes were compared for consistency with baseline demographic, clinical, and economic characteristics for each class. Classes for the control group, corresponding to the identified latent classes for the intervention group, were identified using multinomial logistic regression. Cost-utility analyses were then conducted at the class level, and uncertainty surrounding the point estimates was assessed by probabilistic sensitivity analysis.

RESULTS

The LCA identified three distinct classes: the psychologically care class, the extensive COPD care class, and the limited COPD care class. Patient baseline characteristics were in line with the features identified in the LCA. Evaluation of cost-effectiveness revealed highly disparate results, and case management for only the extensive COPD care class appeared cost-effective with an incremental cost-effectiveness ratio of £26,986 per quality-adjusted life-year gained using the threshold value set by the National Institute of Health and Care Excellence.

CONCLUSIONS

Findings indicate that researchers evaluating patient-tailored complex interventions need to address both supply-side variation and demand-side heterogeneity to link findings with outcome. The article specifically proposes the use of LCA because it is believed to have the potential to enable more appropriate targeting of complex care strategies.

摘要

目的

研究针对患者定制的复杂干预措施成本效益分析中的异质性。

方法

对一项随机对照试验的数据进行潜在类别分析(LCA),该试验评估了针对慢性阻塞性肺疾病(COPD)患者的患者定制病例管理策略。LCA针对代表干预组服务差异的详细过程变量进行。比较所识别潜在类别的特征,以使其与每个类别的基线人口统计学、临床和经济特征保持一致。使用多项逻辑回归确定对照组中与干预组所识别潜在类别相对应的类别。然后在类别层面进行成本效用分析,并通过概率敏感性分析评估点估计周围的不确定性。

结果

LCA识别出三个不同的类别:心理护理类别、广泛COPD护理类别和有限COPD护理类别。患者基线特征与LCA中识别出的特征一致。成本效益评估显示结果差异很大,仅广泛COPD护理类别的病例管理似乎具有成本效益,使用英国国家卫生与临床优化研究所设定的阈值,每获得一个质量调整生命年的增量成本效益比为26,986英镑。

结论

研究结果表明,评估针对患者定制的复杂干预措施的研究人员需要解决供应方差异和需求方异质性问题,以便将研究结果与结果联系起来。本文特别建议使用LCA,因为据信它有可能使复杂护理策略的目标定位更加恰当。

相似文献

1
Examining the Heterogeneity and Cost Effectiveness of a Complex Intervention by Segmentation of Patients with Chronic Obstructive Pulmonary Disease.通过对慢性阻塞性肺疾病患者进行分组来研究一种复杂干预措施的异质性和成本效益。
Value Health. 2018 Feb;21(2):239-247. doi: 10.1016/j.jval.2017.08.001. Epub 2017 Sep 12.
2
Economic Evaluation of Community-Based Case Management of Patients Suffering From Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病患者社区病例管理的经济评估
Appl Health Econ Health Policy. 2017 Jun;15(3):413-424. doi: 10.1007/s40258-016-0298-2.
3
Cost-effectiveness of telehealthcare to patients with chronic obstructive pulmonary disease: results from the Danish 'TeleCare North' cluster-randomised trial.远程医疗对慢性阻塞性肺疾病患者的成本效益:丹麦“北部远程护理”整群随机试验的结果
BMJ Open. 2017 May 17;7(5):e014616. doi: 10.1136/bmjopen-2016-014616.
4
Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.用于评估不同国家慢性阻塞性肺疾病(COPD)患者支气管扩张剂治疗成本效益的概率马尔可夫模型。
Value Health. 2005 Jan-Feb;8(1):32-46. doi: 10.1111/j.1524-4733.2005.03086.x.
5
Estimating the cost-effectiveness of fluticasone propionate for treating chronic obstructive pulmonary disease in the presence of missing data.在存在缺失数据的情况下估算丙酸氟替卡松治疗慢性阻塞性肺疾病的成本效益。
Value Health. 2006 Jul-Aug;9(4):227-35. doi: 10.1111/j.1524-4733.2006.00106.x.
6
Economic benefits of self-management education in COPD.慢性阻塞性肺疾病自我管理教育的经济效益
Chest. 2006 Dec;130(6):1704-11. doi: 10.1378/chest.130.6.1704.
7
Cost-Utility Analysis of Telemonitoring Interventions for Patients with Chronic Obstructive Pulmonary Disease (COPD) in Germany.德国慢性阻塞性肺疾病(COPD)患者远程监测干预措施的成本效益分析。
Appl Health Econ Health Policy. 2016 Dec;14(6):691-701. doi: 10.1007/s40258-016-0267-9.
8
External Validation of Health Economic Decision Models for Chronic Obstructive Pulmonary Disease (COPD): Report of the Third COPD Modeling Meeting.慢性阻塞性肺疾病(COPD)健康经济决策模型的外部验证:第三届COPD建模会议报告
Value Health. 2017 Mar;20(3):397-403. doi: 10.1016/j.jval.2016.10.016. Epub 2017 Jan 3.
9
Rationale and development of a patient-tailored complex intervention of case management for patients suffering from chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者个体化复杂病例管理干预措施的原理与制定
Home Health Care Serv Q. 2017 Jul-Sep;36(3-4):178-195. doi: 10.1080/01621424.2017.1393481. Epub 2017 Nov 10.
10
Cost effectiveness of telehealth for patients with long term conditions (Whole Systems Demonstrator telehealth questionnaire study): nested economic evaluation in a pragmatic, cluster randomised controlled trial.长期病患者的远程医疗的成本效益(全系统示范远程医疗问卷调查研究):在一项实用的、集群随机对照试验中嵌套的经济评估。
BMJ. 2013 Mar 20;346:f1035. doi: 10.1136/bmj.f1035.

引用本文的文献

1
Person-Centred Care in Patients with Acute Coronary Syndrome: Cost-Effectiveness Analysis Alongside a Randomised Controlled Trial.急性冠状动脉综合征患者的以患者为中心的护理:与一项随机对照试验同时进行的成本效益分析。
Pharmacoecon Open. 2019 Dec;3(4):495-504. doi: 10.1007/s41669-019-0126-3.
2
Trajectories of Hospitalization Cost Among Patients of End-Stage Lung Cancer: A Retrospective Study in China.终末期肺癌患者住院费用的变化轨迹:中国的一项回顾性研究。
Int J Environ Res Public Health. 2018 Dec 15;15(12):2877. doi: 10.3390/ijerph15122877.